Project description DEENESFRITPL Automatic detection of colon lesions through a miniature scanner The incidence of colorectal cancer (CRC) is on the rise, and the best prevention is to detect it early. Despite advances in non-invasive techniques, colonoscopy remains the gold standard for CRC screening. The aim of the EU-funded LEAD project is to address colonoscopy limitations with regards to the high number of missed polyps. Researchers have developed a disposable miniature colon spectral scanner that improves polyp detection. Following the promising results from clinical feasibility studies, the project is supporting all the activities necessary for the further development and manufacturing of a fully commercial device. Implementation of the LEAD device is expected to improve the quality of CRC screening programmes. Show the project objective Hide the project objective Objective The lifetime risk of developing colorectal cancer (CRC) is about 1 in 22 for men and 1 in 24 for women and this risk increases with age. CRC represents 22% of the total cancer-related costs. It usually begins as a non-cancerous growth called a polyp that develops on the inner lining of the colon or rectum and grows slowly over a period of 10 to 20 years. Research has confirmed that the single best prevention for colon cancer is the early detection and removal of all colon polyps. When colorectal cancer is found at an early stage, the 5-year relative survival rate is about 90% which makes it suitable for screening programs. LEAD (LEsion Auto-Detector) is a cost-effective (€50), disposable miniature colon spectral scanner that drastically improves polyp detection (99%). It features a 360° light emitting ring that scans the colon, automatically processes different wavelengths from the reflected spectral data and provides real-time alerts based on accurate pathological tissue analysis. The proposed work in Phase 1 of the SME instrument fits into our overall plan to reach the market by contributing the financial resources needed to plan a fast sound wider deployment of LEAD in Europe before a global expansion. Following this, we are aiming to secure vital funding for an important clinical study to prove the efficacy of our revolutionary colonoscope add-on. Fields of science engineering and technologyelectrical engineering, electronic engineering, information engineeringelectronic engineeringsensorsoptical sensorsnatural sciencesbiological sciencesgeneticsDNAmedical and health sciencesclinical medicineoncologycolorectal cancerengineering and technologymedical engineeringmedical laboratory technologylaboratory samples analysis Programme(s) H2020-EU.2.3. - INDUSTRIAL LEADERSHIP - Innovation In SMEs Main Programme H2020-EU.3. - PRIORITY 'Societal challenges H2020-EU.2.1. - INDUSTRIAL LEADERSHIP - Leadership in enabling and industrial technologies Topic(s) EIC-SMEInst-2018-2020 - SME instrument Call for proposal H2020-EIC-SMEInst-2018-2020 See other projects for this call Sub call H2020-SMEInst-2018-2020-1 Funding Scheme SME-1 - SME instrument phase 1 Coordinator SINGER INSTRUMENTS & CONTROL LTD Net EU contribution € 50 000,00 Address YOZMA STREET 2 39032 TIRAT CARMEL Israel See on map SME The organization defined itself as SME (small and medium-sized enterprise) at the time the Grant Agreement was signed. Yes Activity type Private for-profit entities (excluding Higher or Secondary Education Establishments) Links Contact the organisation Opens in new window Website Opens in new window Participation in EU R&I programmes Opens in new window HORIZON collaboration network Opens in new window Total cost € 71 429,00
